Cargando…
Corticosteroids for CAP, influenza and COVID-19: when, how and benefits or harm?
PURPOSE: Corticosteroids have been considered in medicine for a long time, and they are broadly prescribed. In infectious diseases, corticosteroids have been regarded as a thread due to their immunosuppressive effects and therefore their anti-inflammatory properties. MAIN: In recent years, there hav...
Autores principales: | Martin-Loeches, Ignacio, Torres, Antoni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877325/ https://www.ncbi.nlm.nih.gov/pubmed/33568526 http://dx.doi.org/10.1183/16000617.0346-2020 |
Ejemplares similares
-
Final approval for corticosteroids in severe CAP? For sure, in septic shock
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023) -
Corticosteroids for severe CAP: the pros
por: Torres, Antoni
Publicado: (2015) -
Antenatal corticosteroids and COVID-19: balancing benefits and harms
por: Liauw, Jessica, et al.
Publicado: (2020) -
The Risk of Sarcoidosis Misdiagnosis and the Harmful Effect of Corticosteroids When the Disease Picture Is Incomplete
por: Arcana, Raluca Ioana, et al.
Publicado: (2023) -
The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults
por: Carbonell, Raquel, et al.
Publicado: (2023)